Media ReleasesPhylogica

View All Phylogica News


Phylogica, Investor Presentation: Harnessing Biodiversity for Peptide Therapeutics

Corporate Overview
 
-  Operations in Perth, Australia.
 
-  Phylomer peptide libraries derived from most structurally diverse genomes.
 
-  'Discovery Alliance' business model for rapid revenue growth:-
 Already received >$5.8M in committed revenue in less than 4 years.
 
-  Alliances with:-
Joint venture with Cambridge University for target discovery and validation;
Joint venture with the IMB University of Queensland around biosensor development.
 
To view Presentation please download PDF below:
Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?